Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2006
A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient populationMiroslav Merta, Jana Reiterova, Jana Ledvinova, et al.
Arthritis Research & Therapy|March 2, 2011
Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation studyHanns-Martin Lorenz, Wilhelm H Schmitt, Vladimir Tesar, et al.
Renal Failure|January 5, 2026
Serum steroid metabolome pattern is associated with the response to prednisolone therapy of male patients with IgA nephropathyPetr Kosztyu, Martin Hill, Marta Velikova, et al.
Kidney International|May 17, 2017
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patientsStephen P McAdoo, Anisha Tanna, Zdenka Hrušková, et al.
Journal of Nephrology|May 20, 2015
Rituximab for treatment of severe renal disease in ANCA associated vasculitisDuvuru Geetha, Zdenka Hruskova, Marten Segelmark, et al.
Frontiers in Immunology|April 6, 2023
Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitisVeronika Satrapova, Nadja Sparding, Federica Genovese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 2006
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritisMarten Trendelenburg, Margarita Lopez-Trascasa, Eliska Potlukova, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 10, 2021
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021Hans-Joachim Anders, Jerome Loutan, Annette Bruchfeld, et al.
Kidney & Blood Pressure Research|March 5, 2024
The Importance of Early Diagnosis and Intervention in Chronic Kidney Disease: Calls-to-Action from Nephrologists Based Mainly in Central/Eastern EuropeAdrian Covic, Marcus Säemann, Jean Filipov, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2006
A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient populationMiroslav Merta, Jana Reiterova, Jana Ledvinova, et al.
Arthritis Research & Therapy|March 2, 2011
Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation studyHanns-Martin Lorenz, Wilhelm H Schmitt, Vladimir Tesar, et al.
Renal Failure|January 5, 2026
Serum steroid metabolome pattern is associated with the response to prednisolone therapy of male patients with IgA nephropathyPetr Kosztyu, Martin Hill, Marta Velikova, et al.
Kidney International|May 17, 2017
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patientsStephen P McAdoo, Anisha Tanna, Zdenka Hrušková, et al.
Journal of Nephrology|May 20, 2015
Rituximab for treatment of severe renal disease in ANCA associated vasculitisDuvuru Geetha, Zdenka Hruskova, Marten Segelmark, et al.
Frontiers in Immunology|April 6, 2023
Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitisVeronika Satrapova, Nadja Sparding, Federica Genovese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 2006
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritisMarten Trendelenburg, Margarita Lopez-Trascasa, Eliska Potlukova, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 10, 2021
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021Hans-Joachim Anders, Jerome Loutan, Annette Bruchfeld, et al.
Kidney & Blood Pressure Research|March 5, 2024
The Importance of Early Diagnosis and Intervention in Chronic Kidney Disease: Calls-to-Action from Nephrologists Based Mainly in Central/Eastern EuropeAdrian Covic, Marcus Säemann, Jean Filipov, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Pageof 20